在县医院妇科肿瘤门诊向多元化贫困患者群体推广普遍性基因检测
该质量改进项目将普遍性基因检测倡议(UGTI)推广至服务多元化贫困患者的县医院妇科肿瘤门诊,采用改进模型框架实施整合遗传咨询、门诊追踪、协助转诊和提供者教育等干预,回顾性分析241例高级别非黏液性卵巢/输卵管/原发腹膜癌(HGOC)和子宫内膜癌(EC)患者,结果显示HGOC转诊遗传咨询率84.2%、完成遗传咨询89.6%(43/48)、完成基因检测90.7%(39/43);EC免疫组化推荐率81.0%、完成率62.4%(93/149);推广期诊断的患者更可能获得遗传咨询推荐(p=0.02)和完成基因检测(p=0.03),EC患者推广后诊断者更可能完成免疫组化(p<0.001)。
要点
- UGTI可提高贫困多元化妇科癌症患者指南推荐的遗传咨询和基因检测使用率。
- 推广期诊断的HGOC患者更可能获得遗传咨询推荐(p=0.02)和完成基因检测(p=0.03)。
- 推广后诊断的EC患者更可能完成免疫组化(p<0.001)。
核心结论
- UGTI可适用于多元化贫困妇科癌症患者群体,提高指南推荐的癌症遗传学服务使用率。
主要发现
- 研究结束时HGOC患者遗传咨询转诊率为84.2%,完成遗传咨询89.6%(43/48),完成基因检测90.7%(39/43)。
- EC患者免疫组化推荐率为81.0%,完成免疫组化62.4%(93/149)。
- UGTI推广期间诊断的HGOC患者较推广前诊断者更可能获得遗传咨询推荐(p=0.02)和完成基因检测(p=0.03)。
- 推广后诊断的EC患者较推广前诊断者更可能完成免疫组化(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The universal genetic testing initiative (UGTI) is a quality improvement effort to increase rates of guideline-based genetic counseling (GC) and genetic testing (GT) of patients with potentially hereditary cancers. The UGTI was disseminated to a county hospital gynecologic oncology clinic that serves a diverse, indigent patient population. METHODS: Using the Model for Improvement quality improvement framework, interventions including integrated GC, clinic tracking, assisted GC referrals, and provider education were tested over 26 months. A retrospective data review included patients with high-grade, non-mucinous epithelial ovarian, fallopian tube, and primary peritoneal cancers (HGOC) and endometrial cancers (EC) diagnosed between 9/1/12-8/31/16. Statistical analyses were performed to describe the population and to evaluate rates of recommendation and use of immunohistochemistry tumor testing (IHC), GC, and GT. RESULTS: A cohort of 241 patients (57 HGOC, 184 EC) were included. At the conclusion of the study 84.2% of HGOC patients were referred for GC, 89.6% (43/48) completed GC, and 90.7% (39/43) completed GT. Of EC patients, 81.0% were recommended to have IHC and 62.4% (93/149) completed IHC. Patients with HGOC diagnosed during dissemination of UGTI were significantly more likely to receive a recommendation for GC (p = 0.02) and to complete GT (p = 0.03) than those diagnosed before UGTI. Patients with EC were significantly more likely to complete IHC if diagnosed after UGTI than those diagnosed prior to dissemination (p < 0.001). CONCLUSIONS: The UGTI can be adapted to increase use of guideline-based cancer genetics services in a diverse, indigent, gynecologic cancer patient population.
引用
- Bednar EM, Sun CC, Camacho B, et al. Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. Gynecol Oncol. 2018. PMID: 30528888. doi:10.1016/j.ygyno.2018.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。